|
|
|
|
Once-Daily Darunavir/Ritonavir (DRV/r) Versus Atazanavir/Ritonavir (ATV/r) on Insulin Sensitivity in HIV-Infected Persons Over 48 Weeks
|
|
|
Reported by Jules Levin
ICAAC 2013 Sept 10-13 Denver, CO
Edgar Turner Overton,1 Pablo Tebas,2 Robert Ryan,3 Bruce Coate,3 Amy Perniciaro,4 Yaswant K. Dayaram,4 Guy De La Rosa,3 Bryan Baugh4
1University of Alabama School of Medicine, Birmingham, AL, USA; 2University of Pennsylvania, Philadelphia, PA, USA; 3Janssen Research & Development, Titusville, NJ, USA; 4Janssen Services, LLC, Titusville, NJ, USA
|
|
|
|
|
|
|